SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-073202
Filing Date
2024-06-13
Accepted
2024-06-13 18:23:18
Documents
1
Period of Report
2024-06-13

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4032
  Complete submission text file 0000950170-24-073202.txt   5589
Mailing Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075
Business Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 (858) 925-8215
eFFECTOR Therapeutics, Inc. (Issuer) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O IMMUNOGEN, INC. 830 WINTER STREET WALTHAM MA 02451
Business Address
Harrington-Smith Kristen (Reporting) CIK: 0001894310 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39866 | Film No.: 241042509